Logo image of FHTX

FOGHORN THERAPEUTICS INC (FHTX) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:FHTX - US3441741077 - Common Stock

6.08 USD
+0.51 (+9.16%)
Last: 1/21/2026, 8:18:38 PM
6.05 USD
-0.03 (-0.49%)
After Hours: 1/21/2026, 8:18:38 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
FHTX revenue by date.FHTX revenue by date.
19.23M
1,356.82%
34.155M
77.61%
22.602M
-33.83%
31.849M
40.91%
35.631M
11.87%
40.924M
14.86%
58.926M
43.99%
71.388M
21.15%
104.79M
46.79%
196.91M
87.91%
269.96M
37.10%
287.39M
6.46%
EBITDA
YoY % growth
FHTX ebitda by date.FHTX ebitda by date.
-113.84M
-16.71%
-104.455M
8.24%
-97.165M
6.98%
-74.874M
22.94%
-104.742M
-39.89%
-83.977M
19.83%
N/A-135.364M-133.151M
1.64%
-20.012M
84.97%
46.971M
334.71%
107.7M
129.29%
EBIT
YoY % growth
FHTX ebit by date.FHTX ebit by date.
-117.14M
-16.28%
-107.906M
7.88%
-100.285M
7.06%
-81.559M
18.67%
-85.2M
-4.46%
-84.788M
0.48%
-83.313M
1.74%
-83.207M
0.13%
-63.207M
24.04%
-31.217M
50.61%
20.556M
165.85%
81.875M
298.30%
Operating Margin
FHTX operating margin by date.FHTX operating margin by date.
-609.15%-315.93%-443.70%-256.08%-239.12%-207.18%-141.39%-116.56%-60.32%-15.85%7.61%28.49%
EPS
YoY % growth
FHTX eps by date.FHTX eps by date.
-2.62
2.96%
-2.34
10.69%
-1.65
29.49%
-1.13
31.79%
-1.08
4.36%
-1.12
-3.64%
-0.81
27.40%
-0.59
27.37%
-0.12
78.90%
0.28
324.57%
0.67
141.49%
1.15
71.21%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28
EPS
Q2Q % growth
-0.26
13.84%
-0.31
-3.70%
-0.30
-5.70%
-0.30
-19.61%
-0.30
-17.84%
-0.41
-32.13%
-0.42
-41.64%
-0.43
-43.26%
-0.44
-43.34%
-0.44
-8.19%
-0.45
-8.03%
-0.46
-8.33%
Revenue
Q2Q % growth
9.69M
239.29%
6.661M
11.91%
6.979M
-7.65%
7.141M
-12.41%
7.58M
-21.78%
N/AN/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth
-13.694M
34.43%
-25.188M
-14.05%
-25.36M
-30.59%
-24.503M
-53.42%
-27.122M
-98.06%
N/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-17.634M
26.54%
-23.416M
-2.19%
-23.968M
-13.61%
-24.117M
-30.35%
-25.594M
-45.14%
N/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.25
19.35%
-0.340.0926.37%
Q2 2025
Q2Q % growth
-0.28
37.78%
-0.370.0923.44%
Q1 2025
Q2Q % growth
-0.30
49.15%
-0.350.0514.04%
Q4 2024
Q2Q % growth
-0.30
47.37%
-0.330.0310.09%
Q3 2024
Q2Q % growth
-0.31
8.82%
-0.450.1430.99%
Q2 2024
Q2Q % growth
-0.45
35.71%
-0.670.2232.64%
Q1 2024
Q2Q % growth
-0.59
19.18%
-0.650.068.69%
Q4 2023
Q2Q % growth
-0.57
17.39%
-0.780.2126.78%
Q3 2023
Q2Q % growth
-0.34
45.16%
-0.760.4255.54%
Q2 2023
Q2Q % growth
-0.70
-6.06%
-0.750.056.63%
Q1 2023
Q2Q % growth
-0.73
-12.31%
-0.740.011.28%
Q4 2022
Q2Q % growth
-0.69
6.76%
-0.63-0.06-9.46%
Q3 2022
Q2Q % growth
-0.62
12.68%
-0.630.011.96%
Q2 2022
Q2Q % growth
-0.66
-4.76%
-0.60-0.06-9.21%
Q1 2022
Q2Q % growth
-0.65
-4.84%
-0.53-0.12-21.96%
Q4 2021
Q2Q % growth
-0.74
60.22%
-0.50-0.24-48.67%
Q3 2021
Q2Q % growth
-0.71
77.24%
-0.68-0.03-4.41%
Q2 2021
Q2Q % growth
-0.63 -0.640.011.44%
Q1 2021
Q2Q % growth
-0.62 -0.640.023.52%
Q4 2020
Q2Q % growth
-1.86 -0.46-1.40-305.23%
Q3 2020
Q2Q % growth
-3.12 -1.75-1.37-77.84%
FHTX Yearly EPS VS EstimatesFHTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 -1 -2 -3 -4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
8.153M
4.42%
6.321M1.832M28.98%
Q2 2025
Q2Q % growth
7.557M
9.71%
6.628M929K14.02%
Q1 2025
Q2Q % growth
5.952M
17.86%
5.932M20K0.34%
Q4 2024
Q2Q % growth
2.856M
-50.49%
7.483M-4.627M-61.83%
Q3 2024
Q2Q % growth
7.808M
-55.33%
6.465M1.343M20.77%
Q2 2024
Q2Q % growth
6.888M
23.02%
6.161M727K11.80%
Q1 2024
Q2Q % growth
5.05M
-4.88%
7.05M-2M-28.37%
Q4 2023
Q2Q % growth
5.769M
38.01%
4.714M1.055M22.38%
Q3 2023
Q2Q % growth
17.478M
163.62%
4.611M12.867M279.05%
Q2 2023
Q2Q % growth
5.599M
24.70%
6.388M-789K-12.35%
Q1 2023
Q2Q % growth
5.309M
35.43%
5.138M171K3.33%
Q4 2022
Q2Q % growth
4.18M
488.73%
8.648M-4.468M-51.67%
Q3 2022
Q2Q % growth
6.63M
16,475.00%
9.384M-2.754M-29.35%
Q2 2022
Q2Q % growth
4.49M
1,503.57%
8.861M-4.371M-49.33%
Q1 2022
Q2Q % growth
3.92M
1,251.72%
8.619M-4.699M-54.52%
Q4 2021
Q2Q % growth
710K
184.00%
165.75K544.25K328.36%
Q3 2021
Q2Q % growth
40K
-77.78%
170.003K-130.003K-76.47%
Q2 2021
Q2Q % growth
280K 255K25K9.80%
Q1 2021
Q2Q % growth
290K 170.003K119.997K70.58%
Q4 2020
Q2Q % growth
250K 510K-260K-50.98%
Q3 2020
Q2Q % growth
180K 510K-330K-64.71%
FHTX Yearly Revenue VS EstimatesFHTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M 250M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS4.11% 1.45% 0% 7.28%
Revenue-4.89% -17.52% -4.46% -1.97%